(1S,4S)-2-Methyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide is a chiral, bicyclic diamine compound supplied as a dihydrobromide salt. Its structure features a rigid [2.2.1] bicyclic framework containing two nitrogen atoms, one of which is a tertiary amine (methylated) and the other is a secondary amine (protonated as part of the salt). The (1S,4S) stereochemistry indicates a specific, defined spatial arrangement of the atoms. This compound is a crucial chiral building block and intermediate in pharmaceutical synthesis. Its primary and well-documented application is in the preparation of varenicline, a widely used smoking cessation drug (marketed as Chantix®). The rigid, chiral scaffold of this diamine serves as the core structure of varenicline, acting as a partial agonist at the α4β2 nicotinic acetylcholine receptor. Its synthesis and use are predominantly within the context of advanced medicinal chemistry for central nervous system (CNS) active agents. As a high-value chiral synthon, it is not a commodity chemical but a specialized intermediate. The dihydrobromide salt form enhances its stability and handling properties for synthetic operations. Handling requires standard precautions for amine salts and bromides.